Cardiovascular Diagnostic & Monitoring Devices Market

Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cardiovascular Diagnostic & Monitoring Devices Market Outlook 2031

  • The global industry was valued at US$ 14.2 Bn in 2021
  • It is projected to grow at a CAGR of 7.5% between 2022 and 2031 and reach more than US$ 29.0 Bn by the end of 2031

Analysts’ Viewpoint

The global cardiovascular monitoring & diagnostic devices market is driven by rise in prevalence of chronic cardiovascular diseases. Primary causes of cardiovascular disease are high salt intake in diet, increased tobacco use, rise in prevalence of smoking, and surge in alcohol consumption. Cardiovascular diseases can be effectively treated if detected early. Increase in demand for early diagnosis of cardiovascular diseases is likely to accelerate business expansion in the near future.

Launch of new products with novel features is another factor that is expected to boost demand for cardiovascular devices. The cardiovascular diagnostic & monitoring devices industry is expanding at a rapid pace due to rise in the demand for effective and cutting-edge devices to reduce cardiovascular disease-related deaths. Furthermore, incorporation of cutting-edge technologies such as artificial intelligence (AI) in cardiovascular devices improves patient care and reduces cardiac patient mortality.

Cardiovascular Diagnostic And Monitoring Devices Market

Cardiovascular Diagnostic & Monitoring Devices Market Introduction

Cardiac monitoring devices are important in cardiovascular care because these can be used to determine the frequency and severity of cardiac failure, as well as the efficacy of treatments such as drugs, surgeries, and device implants. Cardiovascular disease (CVD), which is preventable, is one of the leading causes of death worldwide. Majority of CVDs can be avoided with pre-monitoring and pre-diagnosis. Arrhythmias, or irregularities in the heartbeat, can be avoided with early detection. Cardiac monitoring products can assist patients who are at high risk of heart disease and help in diagnosis and monitoring of heart disease. This is projected to augment the demand for cardiovascular monitoring & diagnostic devices in the near future.

Doctors' and healthcare networks' adoption of electronic medical records and the integration of medical data with the ubiquitous mobile device have been slow. However, new wireless monitoring tools have emerged and are being used in the treatment of cardiac patients. Development of these wireless cardiac monitoring devices heralds a new era in medicine. It has also led to a shift from population-level health care to individualized medicine, in which qualified healthcare workers are equipped with cutting-edge biosensing, the data from which is prepared through algorithms to predict events before they occur.

Request a sample to get extensive insights into the Cardiovascular Diagnostic & Monitoring Devices Market

Acceptance and Demand for Subcutaneous Cardiac Monitor Devices Driving Industry Expansion

Subcutaneous cardiac monitor devices (SCRMs) are a newer technology used to monitor known arrhythmias such as atrial fibrillation (AF) or to detect infrequent tachy and brady arrhythmias in patients at risk of sudden cardiac death. Cardiac diagnostic & monitoring devices is a rapidly expanding field that could go beyond electrocardiographic (ECG) and blood pressure measurements. To date, the primary focus of cardiac monitoring has been ambulatory ECG (AECG) monitoring. In this context, AECG monitoring has evolved into a diagnostic tool that physicians of various specialties use on a daily basis.

Majority of skin-mounted cardiovascular monitoring & diagnostic devices currently in use concentrate on the ECG. Nevertheless, in the past few years, devices that are implanted in the subcutaneous tissues or, in rare circumstances, other organs (such as the pulmonary arterial circulation), have become more prevalent. Phoenix Cardiac Devices' BACE (Basal Annuloplasty of the Cardio Externally) device received the CE mark in April 2021. Additionally, Philips purchased BioTelemetry, Inc. in December 2020. This acquisition is expected to enable the integration of BioTelemetry's cardiac diagnostics and monitoring services with Philips' patient monitoring services.

Surge in Prevalence of Cardiovascular Diseases

Cardiac monitoring devices help with continuous heart monitoring in order to detect chronic heart conditions such as stroke and heart failure. It should be possible to recognize and monitor the development of the disease by concentrating on structural and functional abnormalities of the heart and arteries.

According to the American Heart Association's 2017 Heart Diseases and Stroke Statistics update, the number of people with heart failure is rising, and is likely to increase by 46% by 2030, leading to more than 8 million people suffering from heart failure. Congestive heart failure affects 22 million people globally, and another 2 million cases are discovered every year. According to the American Heart Association, congestive heart failure, which kills 8.5% of the population of the U.S. each year, is one of the primary causes of death in the country.

Early detection, which leads to more accurate results using cardiovascular monitoring & diagnostic devices than external cardiac monitors, is projected to fuel market development. For instance, in April 2022, Biotricity announced it would formally soon begin selling its FDA-approved wireless wearable cardiac monitoring device, Biotres. Physicians, medical practices, hospitals, and individuals were allowed to pre-order the product since late February 2022.

Detection of Abnormal Heart Pattern and Non-invasive, Painless Procedure

In terms of type, the ECG devices segment is expected to grow at a rapid pace during the forecast period. An ECG (electrocardiogram) device records heartbeats using electric signals, which are then amplified and displayed on an ECG monitor. ECG devices are used to identify different heart diseases and arrhythmias in a person's body and aid in the selection of the best treatment.

The ECG test detects abnormal heart pattern, and is a non-invasive, painless procedure. Four different types of ECG device can be used to assess the body's heart activity during specific conditions or activities. This is anticipated to propel the ECG devices segment during the forecast period.

Rise in Adoption Cardiovascular Diagnostic & Monitoring Devices

Based on end-user, the hospitals segment dominated the cardiovascular diagnostic & monitoring devices market in 2021. This is ascribed to higher rate of adoption and usage than in other healthcare facilities. Improved healthcare infrastructure in both developed & emerging countries and expansion of favorable reimbursement policies are propelling the hospitals segment.

Patients prefer hospitals that practice patient-centered care as they gain more knowledge about it. In other words, hospitals develop a reputation for providing patients with high-quality care, giving them a competitive advantage over organizations that still rely on antiquated procedures. The needs of patients and their families should be the driving force behind an effective hospital system. This entails using personnel and material resources as efficiently as possible in order to save time and money.

Regional Outlook of Global Cardiovascular Diagnostic & Monitoring Devices Market

North America accounted for around 40.0% share of the global business in 2021. This is ascribed to well-established healthcare infrastructure and quick uptake of newer products. Around 5 million people in the U.S. have heart failure and could require ongoing monitoring via ICM, as well as the 4 million people who have recurrent arrhythmia.

The business is anticipated to grow significantly during the forecast period due to high prevalence of heart failure in the U.S. and high healthcare spending on treatment. The cardiovascular diagnostic & monitoring devices market in Canada is likely to witness strong growth between 2022 and 2031 due to developing health care infrastructure. It is likely to be supported by increasing demand for cardiovascular diagnostics & monitoring in North America.

The industry in Asia Pacific is expected to grow at the fastest pace during the forecast period. Developing health care infrastructure is likely to propel the demand between 2021 and 2031.

Analysis of Key Players

The cardiovascular monitoring & diagnostic devices market is highly competitive and dominated by a small group of companies. Key players are forming strategic alliances to increase sales and share. Other strategies used by participants to increase footprint include product line expansion, acquisitions, and mergers. Abbott Laboratories, Biotronik, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, and Nihon Kohden Corporation are the prominent players in the industry.

Request a custom report on Cardiovascular Diagnostic & Monitoring Devices Market

Key Developments in Cardiovascular Diagnostic & Monitoring Devices Market

  • In June 2022, GE Healthcare announced Portrait Mobile, a wireless patient monitoring system that allows for continuous monitoring throughout a patient's stay. The system assists clinicians in detecting signs of patient deterioration. Early detection of patient deterioration could aid in reducing the length of stay and intensive care unit (ICU) admissions, thus improving patient outcomes.
  • In July 2021, Abbott Laboratories announced the launch of the Jot Dx, its latest implantable cardiac monitor (ICM), in the U.S. Doctors and hospitals can use Jot Dx ICM to view all abnormal cardiac rhythm data or to inform via a unique feature that simplifies recorded arrhythmia rhythms. This technology enables remote detection of cardiac arrhythmias in patients, as well as increased diagnostic accuracy. Jot Dx ICM uses SyncUP, a personalized service that provides customized education and training to help patients connect to and stay connected to the ICM.

Major players have been profiled in the report based on parameters such as financial overview, company overview, strategies, product portfolio, segments, and recent developments.

Global Cardiovascular Diagnostic & Monitoring Devices Market Snapshot

Attribute

Detail

Size in 2021

US$ 14.2 Bn

Forecast (Value) in 2031

More than US$ 29.0 Bn

Growth Rate

(CAGR) for 2022–2031

7.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key trend analysis.

Competition Landscape

  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Product
    • ECG Devices
    • Holter Monitors
    • Event Monitors
    • Implantable Loop Recorders
    • Mobile Cardiac Telemetry
  • End-user
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • GE Healthcare
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global cardiovascular diagnostic & monitoring devices market in 2021?

The global industry was valued at US$ 14.2 Bn in 2021

How big will it be in 2031?

It is projected to reach more than US$ 29.0 Bn by 2031

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 7.5% from 2022 to 2031

Which are the prominent trends that affect market growth?

Increase in demand for long-term ECG monitoring and self-care management.

What was the share of the leading segment in 2021?

The ECG devices segment held more than 41% share in 2021

Who are the prominent players in the market?

Abbott Laboratories, Biotronik, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Koninklijke Philips N.V., Medtronic, and Nihon Kohden Corporation.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Cardiovascular Diagnostic & Monitoring Devices Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, 2017–2031

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Disease Prevalence & Incidence Rate

        5.2. Key Product/Brand Analysis

        5.3. Smart wearable devices in cardiovascular care: where we are and how to move forward

        5.4. Value Chain Analysis

        5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. ECG Devices

                6.3.1.1. Resting ECG Devices

                6.3.1.2. Stress ECG Devices

            6.3.2. Holter Monitors

            6.3.3. Event Monitors

            6.3.4. Implantable Loop Recorders

            6.3.5. Mobile Cardiac Telemetry

        6.4. Market Attractiveness Analysis, by Product

    7. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Clinics

            7.3.3. Ambulatory Surgery Centers

            7.3.4. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Product, 2017–2031

            9.2.1. ECG Devices

                9.2.1.1. Resting ECG Devices

                9.2.1.2. Stress ECG Devices

            9.2.2. Holter Monitors

            9.2.3. Event Monitors

            9.2.4. Implantable Loop Recorders

            9.2.5. Mobile Cardiac Telemetry

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Hospitals

            9.3.2. Clinics

            9.3.3. Ambulatory Surgery Centers

            9.3.4. Others

        9.4. Market Value Forecast, by Country, 2017–2031

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. ECG Devices

                10.2.1.1. Resting ECG Devices

                10.2.1.2. Stress ECG Devices

            10.2.2. Holter Monitors

            10.2.3. Event Monitors

            10.2.4. Implantable Loop Recorders

            10.2.5. Mobile Cardiac Telemetry

        10.3. Market Value Forecast, by End-user, 2017–2031

            10.3.1. Hospitals

            10.3.2. Clinics

            10.3.3. Ambulatory Surgery Centers

            10.3.4. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. ECG Devices

                11.2.1.1. Resting ECG Devices

                11.2.1.2. Stress ECG Devices

            11.2.2. Holter Monitors

            11.2.3. Event Monitors

            11.2.4. Implantable Loop Recorders

            11.2.5. Mobile Cardiac Telemetry

        11.3. Market Value Forecast, by End-user, 2017–2031

            11.3.1. Hospitals

            11.3.2. Clinics

            11.3.3. Ambulatory Surgery Centers

            11.3.4. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. ECG Devices

                12.2.1.1. Resting ECG Devices

                12.2.1.2. Stress ECG Devices

            12.2.2. Holter Monitors

            12.2.3. Event Monitors

            12.2.4. Implantable Loop Recorders

            12.2.5. Mobile Cardiac Telemetry

        12.3. Market Value Forecast, by End-user, 2017–2031

            12.3.1. Hospitals

            12.3.2. Clinics

            12.3.3. Ambulatory Surgery Centers

            12.3.4. Others

        12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By End-user

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. ECG Devices

                13.2.1.1. Resting ECG Devices

                13.2.1.2. Stress ECG Devices

            13.2.2. Holter Monitors

            13.2.3. Event Monitors

            13.2.4. Implantable Loop Recorders

            13.2.5. Mobile Cardiac Telemetry

        13.3. Market Value Forecast, by End-user, 2017–2031

            13.3.1. Hospitals

            13.3.2. Clinics

            13.3.3. Ambulatory Surgery Centers

            13.3.4. Others

        13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Product

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player – Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2021

        14.3. Competitive Business Strategies

        14.4. Company Profiles

            14.4.1. Abbott Laboratories

                14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.1.2. Company Financials

                14.4.1.3. Growth Strategies

                14.4.1.4. SWOT Analysis

            14.4.2. Biotronik

                14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.2.2. Company Financials

                14.4.2.3. Growth Strategies

                14.4.2.4. SWOT Analysis

            14.4.3. Boston Scientific Corporation

                14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.3.2. Company Financials

                14.4.3.3. Growth Strategies

                14.4.3.4. SWOT Analysis

            14.4.4. GE Healthcare

                14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.4.2. Company Financials

                14.4.4.3. Growth Strategies

                14.4.4.4. SWOT Analysis

            14.4.5. Medtronic

                14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.5.2. Company Financials

                14.4.5.3. Growth Strategies

                14.4.5.4. SWOT Analysis

            14.4.6. Nihon Kohden Corporation

                14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.4.6.2. Company Financials

                14.4.6.3. Growth Strategies

                14.4.6.4. SWOT Analysis

    List of Tables

    Table 01: Global Stroke Incident Cases

    Table 02: Global Prevalence of Heart Failure (2017)

    Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016–2017

    Table 04: Status of Cardiac Surgeries in North America

    Table 05: New Zealand all cardiac surgery patients in 2016: age and gender

    Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017

    Table 07: Key Product/Brand Analysis of Implantable Loop Recorder

    Table 08: Key Product/Brand Analysis of Holter Monitors

    Table 09: Key Product/Brand Analysis of ECG

    Table 10: Key Product/Brand Analysis of Event Monitors

    Table 11: Key Product/Brand Analysis of Event Monitors

    Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry

    Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018

    Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019

    Table 15: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 16: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 17: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 18: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 20: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 21: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 22: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 31: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 32: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 33: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 35: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 36: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031

    Table 37: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031

    Table 38: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 39: GE Healthcare Business Overview

    Table 40: Koninklijke Philips N.V. Business Overview

    Table 41: Medtronic plc Business Overview

    Table 42: Abbott Laboratories Business Overview

    Table 43: Boston Scientific Corporation Business Overview

    Table 44: Hill-Rom Holdings, Inc. Business Overview

    Table 45: Nihon Kohden Corporation Business Overview

    Table 46: Asahi Kasei Medical Co., Ltd. Business Overview

    List of Figures

    Figure 01: Global Cardiovascular Diagnostic & Monitoring Devices Market Share, by Type

    Figure 02: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031

    Figure 03: Procedures performed in 2017 (New Zealand)

    Figure 04: Procedures performed in 2017 (Australia)

    Figure 05: Value Chain Analysis

    Figure 06: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 07: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 08: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 09: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 10: Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis, by Region

    Figure 11: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031

    Figure 12: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Region, 2021–2031

    Figure 13: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 14: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031

    Figure 15: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country, 2021–2031

    Figure 16: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 17: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 18: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 20: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 21: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 22: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 31: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 32: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 33: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 35: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 36: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 37: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 38: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 39: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 40: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 41: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017–2031

    Figure 42: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 43: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 44: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021–2031

    Figure 45: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031

    Figure 46: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 47: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 48: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 49: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 50: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 51: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 52: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 53: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 54: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 55: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 56: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 57: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020

    Figure 58: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 59: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 60: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 61: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 62: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 63: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 64: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 65: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 66: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 67: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 68: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 69: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020

    Figure 70: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020

    Figure 71: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

    Figure 72: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 73: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 74: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 75: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 76: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2019

    Figure 77: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019

    Figure 78: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019

    Figure 79: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2019

Copyright © Transparency Market Research, Inc. All Rights reserved